Related Experiment Video
Updated: Dec 23, 2025
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
Update on pediatric lung transplantation: mir-ando into the mechanisms of chronic lung allograft dysfunction in
1Stanford Children's Health, Palo Alto, California, USA.
Insights
MicroRNAs show promise as biomarkers for detecting lung allograft dysfunction in pediatric lung transplant recipients. Early detection could lead to better treatments and improved long-term survival after transplantation.
Area of Science:
- Pediatric transplantation
- Molecular biology
- Immunology
Background:
- Lung transplantation (LTx) is a vital treatment for pediatric end-stage lung disease.
- Long-term survival in pediatric LTx is limited by chronic lung allograft dysfunction (CLAD).
- Identifying mechanisms of graft dysfunction is challenging.
Purpose of the Study:
- To review recent findings on microRNA's role in pediatric lung transplant recipients.
- To highlight microRNAs as potential biomarkers for stable grafts versus dysfunction.
- To discuss the implications for early detection and therapeutic interventions.
Main Methods:
- Review of a prospective observational study in pediatric lung transplant recipients.
- Analysis of microRNA expression profiles.
- Utilizing next-generation sequencing techniques.
Main Results:
- Identification of specific microRNA markers for acute rejection and CLAD in pediatric LTx.
- MicroRNAs can distinguish stable patients from those predicted to develop graft dysfunction.
- Biomarkers show high sensitivity and specificity.
Conclusions:
- MicroRNA biomarkers offer potential for early detection of lung allograft dysfunction.
- Next-generation sequencing can facilitate biomarker discovery.
- Future research can build on these findings to improve pediatric LTx outcomes and survival.
Purpose Of Review:
Lung transplantation (LTx) is a worthwhile treatment for children with end-stage lung diseases who have no practicable medical or surgical solutions. But the long-term survival remains the lowest in all solid-organ transplant, with a median survival of 5.7 years, limited by the onset of chronic lung allograft dysfunction (CLAD). This reviews a recent publication in pediatric patients that focuses on translational regulation by microRNA.
Recent Findings:
The mechanisms that cause transplanted lung allografts have been difficult to identify. This review discusses pertinent findings in the first and largest observational prospective study of pediatric lung transplant recipients. The review discusses the relevance of microRNA that distinguish stable patients from those who can be predicted to display graft dysfunction on a molecular panel.
Summary:
The article under review detected highly specific and sensitive markers of both acute rejection and CLAD in pediatric LTx recipients. With the use of next-generation sequencing techniques, biomarkers may soon provide the basis for earlier detection of graft function and stimulate development of therapeutic interventions to impact outcomes and survival. The review touches on the relevance of these findings and how future research can build on them.
Related Concept Videos
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:22MicroRNAs